Using dexamethasone-loaded EVs, IL-8 levels in human umbilical vein endothelial cells (HUVECs) were reduced and systemic inflammatory response syndrome (SIRS) was mitigated in mice after intravenous administration of the nanovesicles loaded with the anti-inflammatory drug [121]. The gene discussed is CXCL8; the disease is systemic inflammatory response syndrome.